万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.lww.com/bloodcoagulation/pages/default.aspx
3、投稿网址：
http://www.editorialmanager.com/bcf/default.aspx
4、官网邮箱：如下。
5、期刊刊期：一年出版八期。
2021年3月25日星期四
期刊邮箱【官网信息】
Publication & Editorial Staff Contacts
Publisher
Michael Richards
Michael.Richards@wolterskluwer.com
Editorial Coordinator
Sneha Iyer
Sneya.Iyer@wolterskluwer.com
Managing Editor
Sarah Booth
Sarah.Booth@wolterskluwer.com
Production Editor
Sascha Milenkovic
Sascha.Milenkovic@wolterskluwer.com
投稿须知【官网信息】
Instructions for Authors
Guidance for Authors on the Preparation and Submission of Manuscripts to Blood Coagulation and Fibrinolysis
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the following article: International Committee of Medical Journal Editors. "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" N Engl J Med 1997;336:309-315. The complete document appears at www.icmje.org.
Full details concerning many of the points below, including standard forms, are provided in the guidelines on the journal's web site (www.bloodcoagulation.com).
Scope
Blood Coagulation and Fibrinolysis is an international fully refereed journal that features review and original research articles on all clinical, laboratory and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on haemostatic components. The journal publishes mutation reports detailing the mutated gene and giving a brief clinical history of the propositus. The journal is particularly interested in studies focused on novel mechanisms of blood coagulation & fibrinolysis activation and regulation; novel therapies (preclinical and clinical) and innovative techniques and assays for studying various aspects of the aforementioned topics of interest. The journal also publishes correspondence, technical reports, short communications and reviews of books, software and new products. The emphasis is on speed of publication.
Points to consider before submission
Redundant or duplicate publication
We ask you to confirm that your paper has not been published in its current form or a substantially similar form (in print or electronically, including on a web site), that it has not been accepted for publication elsewhere, and that it is not under consideration by another publication. The International Committee of Medical Journal Editors has provided details of what is and what is not duplicate or redundant publication (http://www.icmje.org). If you are in doubt (particularly in the case of material that you have posted on a web site), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals. In your covering letter to the editors, draw attention to any published work that concerns the same patients or subjects as the present paper.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared.
Copyright: In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).
A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
Permissions to reproduce previously published material
Authors should include with their submission copies of written permission to reproduce material published elsewhere (such as illustrations) from the copyright holder. Authors are responsible for paying any fees to reproduce material.
Patient consent forms
Patients have a right to privacy that should not be infringed without informed consent. Identifying details (written or photographic) should be omitted if they are not essential, but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve, and a consent form should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. When informed consent has been obtained it should be indicated in the published article.
Ethics committee approval
All authors must confirm that the research was conducted within the guidelines below and under the terms of all relevant local legislation. The Editors reserve the right to judge the appropriateness of the use and treatment of humans or animals in experiments for publication in the journal.
Human experiments: All work must be conducted in accordance with the Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm). Papers describing experimental work on human participants which carries a risk of harm must include (1) a statement that the experiments were conducted with the understanding and the consent of each participant, and (2) a statement that the responsible ethical committee has approved the experiments.
Animal experiments: In papers describing experiments on living animals, include (1) a full description of any anaesthetic and surgical procedure used, and (2) evidence that all possible steps were taken to avoid animals' suffering at each stage of the experiment. In experiments involving the use of muscle relaxants, describe the precautions taken to ensure adequate anaesthesia (J Physiol 1990; 420:xii-xiii).
Experiments on isolated tissues: Indicate precisely how you obtained the donor tissue. The NIH guide for the care and use of laboratory animals (National Institutes of Health Publications No. 80-23, revised 1978) gives guidelines for the acquisition and care of animals.
Authorship
All authors must have read and approved the submission. All authors must meet the criteria for authorship as established by the International Committee of Medical Journal Editors. They must believe that the paper represents honest work and be able to verify the validity of the results reported. You might be interested to read the debate on authorship in general in the British Medical Journal's Authorship collection (http://bmj.com/cgi/collection/authorship). Many of the points covered above are discussed in the New England Journal of Medicine's collection of papers entitled 'Editorials on Journal Policy' (http://authors.nejm.org/Misc/Policies.asp).
Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php
FAQ for open access
http://www.wkopenhealth.com/openaccessfaq.php
Copyright assignment
Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to sign a Copyright Transfer Agreement. They may use material from their paper in other works published by them.
Manuscript Submission
All manuscripts must be submitted online via the journal's Editorial Manager site. http://www.editorialmanager.com/bcf/
First-time users: Please click the Register button and enter the requested information. On successful registration, you will be sent an E-mail containing your user name and password. Print a copy of this information for future reference. Note: If you have received an E-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again, simply log in. Once you have an assigned ID and password, you need not re-register, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the log-in button and log in to the system as an Author. Submit your manuscript according to the author instructions. If you experience any problems, please contact Bethany Tilston, Managing Editor, via email at Bethany.tilston@wolterskluwer.com.
Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate page: Title Page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Margins should be not less than 3 cm. Pages should be numbered consecutively, beginning with the Title Page, and the page number should be placed in the top right hand corner of each page. Include line numbering throughout the text. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.
Authors are invited to list up to four potential reviewers, including their full addresses and their institutional email address.
Article Types
Original Articles: Original articles report on clinical, laboratory, and experimental aspects of haemostasis and thrombosis. The work must be original and neither published, accepted, or submitted for publication elsewhere. Original articles must include a structured abstract of no more than 250 words. Studies lacking a clear hypothesis (e.g. incidental findings from biomarker panels) will not be considered.
Review Article: Review articles focus on specific topics of interest and must include an unstructured abstract limited to 250 words. The process for submitting an unsolicited review includes a mandatory pre-submission consisting of an unstructured abstract and general outline. If the review is deemed to be of potential interest to BCF readers, a submission of the full review with be invited.
Case Report: Case reports should be concise descriptions which primarily focus on unique manifestations or new observations of a clinical case. Case reports should contain an unstructured abstract limited to 150 words. The main text should include a description of the case and discussion about the case. Cases peripherally linked to blood coagulation or fibrinolysis (i.e. as described in the "scope") will not be considered.
Mutation Report: The journal publishes mutation reports detailing the mutated gene and giving a brief clinical history of the propositus. Mutation reports should contain a structured abstract of no more than 150 words. To be considered for publication, the mutation must be novel and causally linked to disorders of blood coagulation or fibrinolysis (i.e. as described in the "scope"). The first description of a mutation in a new population may be considered if it advances knowledge beyond that described in other reports.
Technical Report: Technical reports describe articles focused on technique or technical innovations. With regard to the description of new techniques, non-comparative articles must contain sufficient numbers of patients for the reader to make an educated assessment of the effectiveness and side-effects of the technique; generally this requires experience with several hundred patients. Technical reports must include a structured abstract of no more than 250 words.
Short communications: Short communications present new ideas or reports of pilot studies that include data of particular significance, originality and timeliness. They should contain a structured abstract limited to 150 words.
Letters to Editor: Letters to the Editor can provide additional comment on an article published in BCF or they can be a very concise report on study findings.
Presentation of papers
Title Page
The Title Page should carry the full title of the paper and a short title, of no more than 45 characters and spaces, to be used as a 'running head' (and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. Any disclaimers should appear on the Title Page, as should the name and address of the author responsible for correspondence concerning the manuscript and the name and address of the author to whom requests for reprints should be made. Finally, the Title Page should include the sources of any support for the work in the form of grants, equipment, drugs, or any combination of these. Disclose funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Abstracts
The second page should include an abstract of no more than 250 words. Original Articles, Mutation Reports, Technical Reports, and Short Communications must include a structured abstract. Structured abstracts should state the Objective(s) of the study or investigation, basic Methods (selection of study subjects or laboratory animals; observational and analytical methods), main Results (giving specific data and their statistical significance, if possible), and the principal Conclusions. It should emphasize new and important aspects of the study or observations.
Key Words
The abstract should be followed by a list of 3 - 10 keywords or short phrases which will assist the cross-indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the Index Medicus (http://www.nlm.nih.gov/mesh/meshhome.html).
Text
Full papers of an experimental or observational nature should be divided into sections headed Introduction, Methods (including ethical and statistical information), Results, and Discussion (including a conclusion). Review Articles may require a different format.
Acknowledgements
Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions.
References
References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g. [17]. References should include the names of all authors when six or fewer; when seven or more, list only the first six names and add et al. References should also include full title and source information. Journal names should be abbreviated as in the Index Medicus (http://www.nlm.nih.gov/tsd/serials/terms_cond.html).
Articles in journals
Standard journal article:
Ageno W, Garcia D, Libby E, Crowther MA. Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians. Blood Coagul Fibrinolysis 2004; 15:623-628.
More than seven authors:
Kurose I, Miura S, Fukumura D, Suzuki M, Nagata H, Sekizuka E, et al. Attenuation effect of antithrombin III on the fibrinolytic activation and microvascular derangement in rat gastric mucosa. Thromb Haemost 1994; 71:119-123.
Books
Book:
Giddings JC. Molecular Genetics and Immuno-analysis in Blood Coagulation. Chichester: Ellis Horwood, 1988.
Chapter in a book:
Chong BH, Magnani HN. Danaparoid for the treatment of heparin-induced thrombocytopenia. In: Warketin TE, Greinacher A (editors). Heparin-Induced Thrombocytopenia, 2nd edn. New York: Marcel Dekker; 2001, pp. 323-348.
Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words 'in press' in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
Tables
Tables must be saved in a Word document, separate from the manuscript text. Each table must begin on a new page and should be double-spaced. Each table should be assigned an Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should not be used. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge the source fully.
Illustrations
A) Creating Digital Artwork
Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42
Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B) Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital artwork:
Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution PDF files are also acceptable.
Crop out any white or black space surrounding the image.
Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.v
Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
Remember:
References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2).
Number figures in the figure legend in the order in which they are discussed.
Upload figures consecutively to the Editorial Manager web site and enter figure numbers consecutively in the Description field when uploading the files.
Photomicrographs must have internal scale markers.
If photographs of people are used, their identities must be obscured or the picture must be accompanied by written consent to use the photograph.
If a figure has been published before, the original source must be acknowledged and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain.
Figures may be reduced, cropped or deleted at the discretion of the editor.
Colour illustrations are acceptable but authors will be expected to cover the extra reproduction costs (for current charges, contact the publisher).
Legends for illustrations
Captions should be typed in double spacing, beginning on a separate sheet of paper. Each one should have an Arabic numeral corresponding to the illustration to which it refers. Internal scales should be explained and staining methods for photomicrographs should be identified.
Units of measurement
Measurements of length, height, weight, and volume should be reported in metric units (metre, kilogram, or litre) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimetres of mercury.
All haematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
AFTER ACCEPTANCE
Page Proofs and Corrections
Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Links to portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author by Email. Complete instructions will be provided with the Email for downloading and printing the files and for faxing the corrected page proofs to the publisher. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections submitted within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Publish Ahead of Print
Accepted manuscripts will be posted online ahead of print in the order of acceptance. The accepted version of the manuscript, prior to proof corrections, will be posted. All manuscripts will appear on the Journal web site in a special tab that contains the full queue of publish-ahead-of-print manuscripts. They will also appear in Ovid Gateway in a special table of contents, and header information (title, author information, abstract, etc.) will be delivered to PubMed. Each manuscript will be referenced via a permanent digital object identifier which will remain unique to that manuscript even after the full issue is released to press. Once a manuscript is released to press, the publish-ahead-of-print version will be removed from the Ovid Gateway and Journal website publish-ahead-of-print queues.
Offprints
Offprints may be purchased using the appropriate form that will be made available with proofs. Orders should be sent when the proofs are returned; orders received after this time cannot be fulfilled.
